Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Prostate Cancer

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 125 articles: HTML format

Single Articles

July 2008
1. CARUSO DJ , Carmack AJ, Lokeshwar VB, Duncan RC, et al
   Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer Recurrence.
   Clin Cancer Res. 2008;14:4111-8.
   PubMed     Related articles    Abstract available
   
   
   June 2008
2. HOLT SK , Karyadi DM, Kwon EM, Stanford JL, et al
   Association of megalin genetic polymorphisms with prostate cancer risk and prognosis.
   Clin Cancer Res. 2008;14:3823-31.
   PubMed     Related articles    Abstract available
   
   
   
3. LIU JW , Nagpal JK, Sun W, Lee J, et al
   ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer.
   Clin Cancer Res. 2008;14:3754-60.
   PubMed     Related articles    Abstract available
   
   
   
4. LIN SH , Lee YC, Choueiri MB, Wen S, et al
   Soluble ErbB3 Levels in Bone Marrow and Plasma of Men with Prostate Cancer.
   Clin Cancer Res. 2008;14:3729-36.
   PubMed     Related articles    Abstract available
   
   
   
5. MYRTHUE A , Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, et al
   The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells.
   Clin Cancer Res. 2008;14:3562-70.
   PubMed     Related articles    Abstract available
   
   
   
6. TEIXEIRA AL , Ribeiro R, Cardoso D, Pinto D, et al
   Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
   Clin Cancer Res. 2008;14:3367-71.
   PubMed     Related articles    Abstract available
   
   
   May 2008
7. TORKKO KC , van Bokhoven A, Mai P, Beuten J, et al
   VDR and SRD5A2 Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non-Hispanic White and Hispanic White Men.
   Clin Cancer Res. 2008;14:3223-3229.
   PubMed     Related articles    Abstract available
   
   
   
8. GARCIA JA , Klein EA, Magi-Galluzzi C, Elson P, et al
   Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.
   Clin Cancer Res. 2008;14:3052-9.
   PubMed     Related articles    Abstract available
   
   
   
9. MEASE RC , Dusich CL, Foss CA, Ravert HT, et al
   N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer.
   Clin Cancer Res. 2008;14:3036-43.
   PubMed     Related articles    Abstract available
   
   
   
10. TANG Y , Wang L, Goloubeva O, Afnan Khan M, et al
    Divergent Effects of Castration on Prostate Cancer in TRAMP Mice: Possible Implications for Therapy.
    Clin Cancer Res. 2008;14:2936-43.
    PubMed     Related articles    Abstract available
    
    
    
11. BERTHOLD DR , Pond GR, Roessner M, de Wit R, et al
    Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study.
    Clin Cancer Res. 2008;14:2763-2767.
    PubMed     Related articles    Abstract available
    
    
    
12. MOROTE J , Fernandez S, Alana L, Iglesias C, et al
    PTOV1 Expression Predicts Prostate Cancer in Men with Isolated High-Grade Prostatic Intraepithelial Neoplasia in Needle Biopsy.
    Clin Cancer Res. 2008;14:2617-22.
    PubMed     Related articles    Abstract available
    
    
    April 2008
13. ATTIA S , Eickhoff J, Wilding G, McNeel D, et al
    Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer.
    Clin Cancer Res. 2008;14:2437-43.
    PubMed     Related articles    Abstract available
    
    
    March 2008
14. KOSARI F , Munz JM, Savci-Heijink CD, Spiro C, et al
    Identification of prognostic biomarkers for prostate cancer.
    Clin Cancer Res. 2008;14:1734-43.
    PubMed     Related articles    Abstract available
    
    
    
15. LOGOTHETIS CJ , Navone NM, Lin SH
    Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
    Clin Cancer Res. 2008;14:1599-602.
    PubMed     Related articles    Abstract available
    
    
    
16. CHOY H , Park C, Yao M
    Current status and future prospects for satraplatin, an oral platinum analogue.
    Clin Cancer Res. 2008;14:1633-8.
    PubMed     Related articles    Abstract available
    
    
    
17. KARAM JA , Svatek RS, Karakiewicz PI, Gallina A, et al
    Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Clin Cancer Res. 2008;14:1418-22.
    PubMed     Related articles    Abstract available
    
    
    
18. LIN B , Utleg AG, Gravdal K, White JT, et al
    WDR19 Expression is Increased in Prostate Cancer Compared with Normal Cells, but Low-Intensity Expression in Cancers is Associated with Shorter Time to Biochemical Failures and Local Recurrence.
    Clin Cancer Res. 2008;14:1397-406.
    PubMed     Related articles    Abstract available
    
    
    
19. DAGVADORJ A , Kirken RA, Leiby B, Karras J, et al
    Transcription Factor Signal Transducer and Activator of Transcription 5 Promotes Growth of Human Prostate Cancer Cells In vivo.
    Clin Cancer Res. 2008;14:1317-24.
    PubMed     Related articles    Abstract available
    
    
    
20. O'ROURKE M , Ward C, Worthington J, McKenna J, et al
    Evaluation of the antiangiogenic potential of AQ4N.
    Clin Cancer Res. 2008;14:1502-9.
    PubMed     Related articles    Abstract available
    
    
    
21. JENNEWEIN M , Lewis MA, Zhao D, Tsyganov E, et al
    Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.
    Clin Cancer Res. 2008;14:1377-85.
    PubMed     Related articles    Abstract available
    
    
    February 2008
22. HU H , Li GX, Wang L, Watts J, et al
    Methylseleninic Acid Enhances Taxane Drug Efficacy against Human Prostate Cancer and Down-Regulates Antiapoptotic Proteins Bcl-XL and Survivin.
    Clin Cancer Res. 2008;14:1150-8.
    PubMed     Related articles    Abstract available
    
    
    
23. YOKOKAWA J , Cereda V, Remondo C, Gulley JL, et al
    Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer.
    Clin Cancer Res. 2008;14:1032-40.
    PubMed     Related articles    Abstract available
    
    
    
24. RAVEL D , Dubois V, Quinonero J, Meyer-Losic F, et al
    Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin.
    Clin Cancer Res. 2008;14:1258-65.
    PubMed     Related articles    Abstract available
    
    
    
25. HAHM ER , Arlotti JA, Marynowski SW, Singh SV, et al
    Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Clin Cancer Res. 2008;14:1248-57.
    PubMed     Related articles    Abstract available
    
    
    
26. STERBIS JR , Gao C, Furusato B, Chen Y, et al
    Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival.
    Clin Cancer Res. 2008;14:758-63.
    PubMed     Related articles    Abstract available
    
    
    
27. RYBICKI BA , Neslund-Dudas C, Bock CH, Rundle A, et al
    Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomy.
    Clin Cancer Res. 2008;14:750-7.
    PubMed     Related articles    Abstract available
    
    
    
28. LERNER I , Baraz L, Pikarsky E, Meirovitz A, et al
    Function of heparanase in prostate tumorigenesis: potential for therapy.
    Clin Cancer Res. 2008;14:668-76.
    PubMed     Related articles    Abstract available
    
    
    January 2008
29. SHARIAT SF , Lamb DJ, Iyengar RG, Roehrborn CG, et al
    Herbal/Hormonal dietary supplement possibly associated with prostate cancer progression.
    Clin Cancer Res. 2008;14:607-11.
    PubMed     Related articles    Abstract available
    
    
    
30. ZHANG L , Gao L, Li Y, Lin G, et al
    Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
    Clin Cancer Res. 2008;14:559-68.
    PubMed     Related articles    Abstract available
    
    
    
31. DIPAOLA RS , Gallo MA
    Hearsay medicine is not evidence-based medicine.
    Clin Cancer Res. 2008;14:337-8.
    PubMed     Related articles   
    
    
    
32. DAHUT WL , Scripture C, Posadas E, Jain L, et al
    A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer.
    Clin Cancer Res. 2008;14:209-214.
    PubMed     Related articles    Abstract available
    
    
    
33. LI X , Liu YH, Lee SJ, Gardner TA, et al
    Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
    Clin Cancer Res. 2008;14:291-9.
    PubMed     Related articles    Abstract available
    
    
    December 2007
34. XIAO Z , Halls S, Dickey D, Tulip J, et al
    Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of dunning prostate carcinomas.
    Clin Cancer Res. 2007;13:7496-505.
    PubMed     Related articles    Abstract available
    
    
    
35. ZHANG X , Li W, Olumi AF
    Low-dose 12-o-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Clin Cancer Res. 2007;13:7181-90.
    PubMed     Related articles    Abstract available
    
    
    
36. DANILA DC , Heller G, Gignac GA, Gonzalez-Espinoza R, et al
    Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer.
    Clin Cancer Res. 2007;13:7053-7058.
    PubMed     Related articles    Abstract available
    
    
    
37. DIALLO JS , Aldejmah A, Mouhim AF, Peant B, et al
    NOXA and PUMA Expression Add to Clinical Markers in Predicting Biochemical Recurrence of Prostate Cancer Patients in a Survival Tree Model.
    Clin Cancer Res. 2007;13:7044-7052.
    PubMed     Related articles    Abstract available
    
    
    
38. GRAVDAL K , Halvorsen OJ, Haukaas SA, Akslen LA, et al
    A switch from e-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.
    Clin Cancer Res. 2007;13:7003-11.
    PubMed     Related articles    Abstract available
    
    
    
39. KINIWA Y , Miyahara Y, Wang HY, Peng W, et al
    CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer.
    Clin Cancer Res. 2007;13:6947-58.
    PubMed     Related articles    Abstract available
    
    
    November 2007
40. HUANG SP , Huang CY, Wang JS, Liu CC, et al
    Prognostic Significance of p53 and X-ray Repair Cross-complementing Group 1 Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer Post Radical Prostatectomy.
    Clin Cancer Res. 2007;13:6632-6638.
    PubMed     Related articles    Abstract available
    
    
    
41. SCHLOMM T , Kirstein P, Iwers L, Daniel B, et al
    Clinical Significance of Epidermal Growth Factor Receptor Protein Overexpression and Gene Copy Number Gains in Prostate Cancer.
    Clin Cancer Res. 2007;13:6579-6584.
    PubMed     Related articles    Abstract available
    
    
    
42. STISH BJ , Chen H, Shu Y, Panoskaltsis-Mortari A, et al
    A Bispecific Recombinant Cytotoxin (DTEGF13) Targeting Human Interleukin-13 and Epidermal Growth Factor Receptors in a Mouse Xenograft Model of Prostate Cancer.
    Clin Cancer Res. 2007;13:6486-6493.
    PubMed     Related articles    Abstract available
    
    
    
43. PLYMATE SR , Haugk K, Coleman I, Woodke L, et al
    An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer.
    Clin Cancer Res. 2007;13:6429-6439.
    PubMed     Related articles    Abstract available
    
    
    
44. ARMSTRONG AJ , Garrett-Mayer ES, Yang YC, de Wit R, et al
    A Contemporary Prognostic Nomogram for Men with Hormone-Refractory Metastatic Prostate Cancer: A TAX327 Study Analysis.
    Clin Cancer Res. 2007;13:6396-6403.
    PubMed     Related articles    Abstract available
    
    
    October 2007
45. VINALL RL , Hwa K, Ghosh P, Pan CX, et al
    Combination Treatment of Prostate Cancer Cell Lines with Bioactive Soy Isoflavones and Perifosine Causes Increased Growth Arrest and/or Apoptosis.
    Clin Cancer Res. 2007;13:6204-16.
    PubMed     Related articles    Abstract available
    
    
    
46. HENRIQUE R , Ribeiro FR, Fonseca D, Hoque MO, et al
    High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients.
    Clin Cancer Res. 2007;13:6122-6129.
    PubMed     Related articles    Abstract available
    
    
    
47. SELIGSON DB , Hongo F, Huerta-Yepez S, Mizutani Y, et al
    Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence.
    Clin Cancer Res. 2007;13:6056-6063.
    PubMed     Related articles    Abstract available
    
    
    
48. WANG R , Xu J, Mabjeesh N, Zhu G, et al
    PrLZ Is Expressed in Normal Prostate Development and in Human Prostate Cancer Progression.
    Clin Cancer Res. 2007;13:6040-8.
    PubMed     Related articles    Abstract available
    
    
    
49. SHOOK SJ , Beuten J, Torkko KC, Johnson-Pais TL, et al
    Association of RNASEL Variants with Prostate Cancer Risk in Hispanic Caucasians and African Americans.
    Clin Cancer Res. 2007;13:5959-5964.
    PubMed     Related articles    Abstract available
    
    
    
50. MATHEW P , Thall PF, Bucana CD, Oh WK, et al
    Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases.
    Clin Cancer Res. 2007;13:5816-24.
    PubMed     Related articles    Abstract available
    
    
    
51. LU S , Lee J, Revelo M, Wang X, et al
    Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Clin Cancer Res. 2007;13:5692-702.
    PubMed     Related articles    Abstract available
    
    
    
52. NARAYANAN BA , Reddy BS, Bosland MC, Nargi D, et al
    Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
    Clin Cancer Res. 2007;13:5965-73.
    PubMed     Related articles    Abstract available
    
    
    
53. HUANG CY , Beer TM, Higano CS, True LD, et al
    Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
    Clin Cancer Res. 2007;13:5825-33.
    PubMed     Related articles    Abstract available
    
    
    September 2007
54. SHARIAT SF , Bensalah K, Karam JA, Roehrborn CG, et al
    Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer.
    Clin Cancer Res. 2007;13:5377-84.
    PubMed     Related articles    Abstract available
    
    
    
55. BASTIAN PJ , Palapattu GS, Yegnasubramanian S, Lin X, et al
    Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy.
    Clin Cancer Res. 2007;13:5361-5367.
    PubMed     Related articles    Abstract available
    
    
    
56. ZHENG X , Cui XX, Avila GE, Huang MT, et al
    Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    
57. LI X , Liu YH, Zhang YP, Zhang S, et al
    Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    
58. LINDSTROM S , Adami HO, Balter KA, Xu J, et al
    Inherited variation in hormone-regulating genes and prostate cancer survival.
    Clin Cancer Res. 2007;13:5156-61.
    PubMed     Related articles    Abstract available
    
    
    
59. HESSELS D , Smit FP, Verhaegh GW, Witjes JA, et al
    Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer.
    Clin Cancer Res. 2007;13:5103-8.
    PubMed     Related articles    Abstract available
    
    
    
60. HIRATA H , Hinoda Y, Kikuno N, Kawamoto K, et al
    CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility.
    Clin Cancer Res. 2007;13:5056-62.
    PubMed     Related articles    Abstract available
    
    
    
61. LIU W , Chang BL, Cramer S, Koty PP, et al
    Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers.
    Clin Cancer Res. 2007;13:5028-33.
    PubMed     Related articles    Abstract available
    
    
    July 2007
62. BJARTELL AS , Al-Ahmadie H, Serio AM, Eastham JA, et al
    Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
    Clin Cancer Res. 2007;13:4130-8.
    PubMed     Related articles    Abstract available
    
    
    
63. AGARWAL N , Fletcher D, Ward J
    Obesity and treatment of prostate cancer: what is the right dose of lupron depot?
    Clin Cancer Res. 2007;13:4027.
    PubMed     Related articles   
    
    
    
64. SMALL EJ , Sacks N, Nemunaitis J, Urba WJ, et al
    Granulocyte macrophage colony-stimulating factor-secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
    Clin Cancer Res. 2007;13:3883-91.
    PubMed     Related articles    Abstract available
    
    
    
65. BEDOLLA R , Prihoda TJ, Kreisberg JI, Malik SN, et al
    Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation.
    Clin Cancer Res. 2007;13:3860-7.
    PubMed     Related articles    Abstract available
    
    
    
66. DURSO RJ , Andjelic S, Gardner JP, Margitich DJ, et al
    A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.
    Clin Cancer Res. 2007;13:3999-4008.
    PubMed     Related articles    Abstract available
    
    
    
67. KWABI-ADDO B , Chung W, Shen L, Ittmann M, et al
    Age-related DNA methylation changes in normal human prostate tissues.
    Clin Cancer Res. 2007;13:3796-802.
    PubMed     Related articles    Abstract available
    
    
    June 2007
68. KHOR LY , Moughan J, Al-Saleem T, Hammond EH, et al
    Bcl-2 and bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
    Clin Cancer Res. 2007;13:3585-90.
    PubMed     Related articles    Abstract available
    
    
    
69. RAJENDRAN RR , Kao GD
    "No Turning Bax" in the Combined Battle against Prostate Cancer:.
    Clin Cancer Res. 2007;13:3435-8.
    PubMed     Related articles   
    
    
    
70. JOHANSEN JS , Brasso K, Iversen P, Teisner B, et al
    Changes of Biochemical Markers of Bone Turnover and YKL-40 Following Hormonal Treatment for Metastatic Prostate Cancer Are Related to Survival.
    Clin Cancer Res. 2007;13:3244-3249.
    PubMed     Related articles    Abstract available
    
    
    
71. HAYES NV , Blackburn E, Smart LV, Boyle MM, et al
    Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer.
    Clin Cancer Res. 2007;13:3147-55.
    PubMed     Related articles    Abstract available
    
    
    
72. GARCIA FU , Urbanska K, Koltowski L, Reiss K, et al
    Insulin-like growth factor-I produced by seminal vesicles: relationship to intraepithelial basal cell hyperplasia in the prostate.
    Clin Cancer Res. 2007;13:3140-6.
    PubMed     Related articles    Abstract available
    
    
    May 2007
73. KUMAR AP , Bhaskaran S, Ganapathy M, Crosby K, et al
    Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract.
    Clin Cancer Res. 2007;13:2784-94.
    PubMed     Related articles    Abstract available
    
    
    
74. BANYARD J , Bao L, Hofer MD, Zurakowski D, et al
    Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases.
    Clin Cancer Res. 2007;13:2634-42.
    PubMed     Related articles    Abstract available
    
    
    
75. KAWAMOTO K , Okino ST, Place RF, Urakami S, et al
    Epigenetic Modifications of RASSF1A Gene through Chromatin Remodeling in Prostate Cancer.
    Clin Cancer Res. 2007;13:2541-8.
    PubMed     Related articles    Abstract available
    
    
    April 2007
76. WANG JC , Begin LR, Berube NG, Chevalier S, et al
    Down-Regulation of CD9 Expression during Prostate Carcinoma Progression Is Associated with CD9 mRNA Modifications.
    Clin Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
77. YIN Y , Ni J, Chen M, Dimaggio MA, et al
    The Therapeutic and Preventive Effect of RRR-{alpha}-Vitamin E Succinate on Prostate Cancer via Induction of Insulin-Like Growth Factor Binding Protein-3.
    Clin Cancer Res. 2007;13:2271-80.
    PubMed     Related articles    Abstract available
    
    
    
78. ZORN CS , Wojno KJ, McCabe MT, Kuefer R, et al
    5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancer.
    Clin Cancer Res. 2007;13:2136-43.
    PubMed     Related articles    Abstract available
    
    
    
79. RYAN CJ , Halabi S, Ou SS, Vogelzang NJ, et al
    Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
    Clin Cancer Res. 2007;13:2030-7.
    PubMed     Related articles    Abstract available
    
    
    
80. SHAFFER DR , Leversha MA, Danila DC, Lin O, et al
    Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer.
    Clin Cancer Res. 2007;13:2023-2029.
    PubMed     Related articles    Abstract available
    
    
    
81. GROSS M , Top I, Laux I, Katz J, et al
    {beta}-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer.
    Clin Cancer Res. 2007;13:1979-86.
    PubMed     Related articles    Abstract available
    
    
    
82. FREDERIKSEN LJ , Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, et al
    Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
    Clin Cancer Res. 2007;13:2199-206.
    PubMed     Related articles    Abstract available
    
    
    March 2007
83. HOWARD EW , Ling MT, Chua CW, Cheung HW, et al
    Garlic-Derived S-allylmercaptocysteine Is a Novel In vivo Antimetastatic Agent for Androgen-Independent Prostate Cancer.
    Clin Cancer Res. 2007;13:1847-56.
    PubMed     Related articles    Abstract available
    
    
    
84. SMALL EJ , Tchekmedyian NS, Rini BI, Fong L, et al
    A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer.
    Clin Cancer Res. 2007;13:1810-5.
    PubMed     Related articles    Abstract available
    
    
    
85. ROUPRET M , Hupertan V, Yates DR, Catto JW, et al
    Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Clin Cancer Res. 2007;13:1720-5.
    PubMed     Related articles    Abstract available
    
    
    
86. FENG S , Agoulnik IU, Bogatcheva NV, Kamat AA, et al
    Relaxin promotes prostate cancer progression.
    Clin Cancer Res. 2007;13:1695-702.
    PubMed     Related articles    Abstract available
    
    
    
87. ADHAMI VM , Malik A, Zaman N, Sarfaraz S, et al
    Combined Inhibitory Effects of Green Tea Polyphenols and Selective Cyclooxygenase-2 Inhibitors on the Growth of Human Prostate Cancer Cells Both In vitro and In vivo.
    Clin Cancer Res. 2007;13:1611-9.
    PubMed     Related articles    Abstract available
    
    
    
88. NESSLINGER NJ , Sahota RA, Stone B, Johnson K, et al
    Standard treatments induce antigen-specific immune responses in prostate cancer.
    Clin Cancer Res. 2007;13:1493-502.
    PubMed     Related articles    Abstract available
    
    
    
89. SCHER HI , Warren M, Heller G
    The Association Between Measures of Progression and Survival in Castrate-Metastatic Prostate Cancer.
    Clin Cancer Res. 2007;13:1488-1492.
    PubMed     Related articles    Abstract available
    
    
    
90. HUANG YC , Lee CM, Chen M, Chung MY, et al
    Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
    Clin Cancer Res. 2007;13:1412-20.
    PubMed     Related articles    Abstract available
    
    
    February 2007
91. EFSTATHIOU E , Troncoso P, Wen S, Do KA, et al
    Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer.
    Clin Cancer Res. 2007;13:1224-31.
    PubMed     Related articles    Abstract available
    
    
    
92. DREICER R , Petrylak D, Agus D, Webb I, et al
    Phase I/II Study of Bortezomib Plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer.
    Clin Cancer Res. 2007;13:1208-1215.
    PubMed     Related articles    Abstract available
    
    
    
93. MIYAKE H , Hara I, Kurahashi T, Inoue TA, et al
    Quantitative Detection of Micrometastases in Pelvic Lymph Nodes in Patients with Clinically Localized Prostate Cancer by Real-time Reverse Transcriptase-PCR.
    Clin Cancer Res. 2007;13:1192-7.
    PubMed     Related articles    Abstract available
    
    
    
94. HU L , Au JL, Wientjes MG
    Computational modeling to predict effect of treatment schedule on drug delivery to prostate in humans.
    Clin Cancer Res. 2007;13:1278-87.
    PubMed     Related articles    Abstract available
    
    
    
95. HALVORSEN OJ , Rostad K, Oyan AM, Puntervoll H, et al
    Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer.
    Clin Cancer Res. 2007;13:892-897.
    PubMed     Related articles    Abstract available
    
    
    
96. AGALLIU I , Kwon EM, Zadory D, McIntosh L, et al
    Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer.
    Clin Cancer Res. 2007;13:839-43.
    PubMed     Related articles    Abstract available
    
    
    
97. O'MAHONY D , Morris JC, Quinn C, Gao W, et al
    A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy.
    Clin Cancer Res. 2007;13:958-64.
    PubMed     Related articles    Abstract available
    
    
    
98. VAN GILS MP , Hessels D, van Hooij O, Jannink SA, et al
    The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
    Clin Cancer Res. 2007;13:939-43.
    PubMed     Related articles    Abstract available
    
    
    January 2007
99. MEHRA N , Penning M, Maas J, van Daal N, et al
    Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer.
    Clin Cancer Res. 2007;13:421-6.
    PubMed     Related articles    Abstract available
    
    
    
100. SMITH MR
     Obesity and Sex Steroids during Gonadotropin-Releasing Hormone Agonist Treatment for Prostate Cancer.
     Clin Cancer Res. 2007;13:241-5.
     PubMed     Related articles    Abstract available
     
     
     December 2006
101. HAMMARSTEN P , Halin S, Wikstom P, Henriksson R, et al
     Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.
     Clin Cancer Res. 2006;12:7431-6.
     PubMed     Related articles    Abstract available
     
     
     
102. FELTQUATE D , Nordquist L, Eicher C, Morris M, et al
     Rapid Androgen Cycling as Treatment for Patients with Prostate Cancer.
     Clin Cancer Res. 2006;12:7414-7421.
     PubMed     Related articles    Abstract available
     
     
     November 2006
103. XIAO D , Lew KL, Kim YA, Zeng Y, et al
     Diallyl Trisulfide Suppresses Growth of PC-3 Human Prostate Cancer Xenograft In vivo in Association with Bax and Bak Induction.
     Clin Cancer Res. 2006;12:6836-43.
     PubMed     Related articles    Abstract available
     
     
     
104. NAM RK , Zhang WW, Klotz LH, Trachtenberg J, et al
     Variants of the hK2 Protein Gene (KLK2) Are Associated with Serum hK2 Levels and Predict the Presence of Prostate Cancer at Biopsy.
     Clin Cancer Res. 2006;12:6452-8.
     PubMed     Related articles    Abstract available
     
     
     October 2006
105. SMITH MR
     Treatment-related osteoporosis in men with prostate cancer.
     Clin Cancer Res. 2006;12:6315s-9s.
     PubMed     Related articles    Abstract available
     
     
     
106. CARDUCCI MA , Jimeno A
     Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
     Clin Cancer Res. 2006;12:6296s-300s.
     PubMed     Related articles    Abstract available
     
     
     
107. VESSELLA RL , Corey E
     Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
     Clin Cancer Res. 2006;12:6285s-90s.
     PubMed     Related articles    Abstract available
     
     
     
108. WU JD , Haugk K, Coleman I, Woodke L, et al
     Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors.
     Clin Cancer Res. 2006;12:6153-60.
     PubMed     Related articles    Abstract available
     
     
     
109. YOSHINO T , Shiina H, Urakami S, Kikuno N, et al
     Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy.
     Clin Cancer Res. 2006;12:6116-24.
     PubMed     Related articles    Abstract available
     
     
     
110. HAHN NM , Marsh S, Fisher W, Langdon R, et al
     Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis.
     Clin Cancer Res. 2006;12:6094-9.
     PubMed     Related articles    Abstract available
     
     
     
111. YANO A , Fujii Y, Iwai A, Kawakami S, et al
     Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
     Clin Cancer Res. 2006;12:6012-7.
     PubMed     Related articles    Abstract available
     
     
     
112. POOTRAKUL L , Datar RH, Shi SR, Cai J, et al
     Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer.
     Clin Cancer Res. 2006;12:5987-5993.
     PubMed     Related articles    Abstract available
     
     
     
113. HURRIA A , Fleming MT, Baker SD, Kelly WK, et al
     Pharmacokinetics and toxicity of weekly docetaxel in older patients.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
114. REEVES JR , Dulude H, Panchal C, Daigneault L, et al
     Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
115. BRULAND OS , Nilsson S, Fisher DR, Larsen RH, et al
     High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
116. COLEMAN RE
     Clinical features of metastatic bone disease and risk of skeletal morbidity.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
117. GUISE TA , Mohammad KS, Clines G, Stebbins EG, et al
     Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     
118. LI H , Tai BC
     RNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis.
     Clin Cancer Res. 2006;12:5713-5719.
     PubMed     Related articles    Abstract available
     
     
     
119. BANACH-PETROSKY W , Ouyang X, Gao H, Nader K, et al
     Vitamin d inhibits the formation of prostatic intraepithelial neoplasia in nkx3.1; pten mutant mice.
     Clin Cancer Res. 2006;12:5895-901.
     PubMed     Related articles    Abstract available
     
     
     
120. LESSARD L , Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, et al
     Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases.
     Clin Cancer Res. 2006;12:5741-5.
     PubMed     Related articles    Abstract available
     
     
     September 2006
121. DOMINGO-DOMENECH J , Oliva C, Rovira A, Codony-Servat J, et al
     Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
     Clin Cancer Res. 2006;12:5578-86.
     PubMed     Related articles    Abstract available
     
     
     
122. CARVER BS , Pandolfi PP
     Mouse modeling in oncologic preclinical and translational research.
     Clin Cancer Res. 2006;12:5305-11.
     PubMed     Related articles    Abstract available
     
     
     August 2006
123. TAHIR SA , Frolov A, Hayes TG, Mims MP, et al
     Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
     Clin Cancer Res. 2006;12:4872-5.
     PubMed     Related articles    Abstract available
     
     
     July 2006
124. SIRCAR K , Gaboury L, Ouadi L, Mecteau M, et al
     Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens.
     Clin Cancer Res. 2006;12.
     PubMed     Related articles    Abstract available
     
     
     April 2006
125. MA D , Hopf CE, Malewicz AD, Donovan GP, et al
     Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.
     Clin Cancer Res. 2006;12:2591-6.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: